Desq Long
Sign in

Cluster

BOLT-2026-06-05-d6b2eb5a5c3a

SEC FORM 4CLUSTER · 2 INSIDERS
$4,441.89

Bolt Biotherapeutics, Inc. (BOLT)

Purchase of 1,146 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Quinn William P., President, CEO and CFOPurchase of 637 shares at $3.876 per share.$2,469.01
  • Nemec Sarah, Senior VP, Finance and PAOPurchase of 509 shares at $3.876 per share.$1,972.88

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Jun 5, 2026 · Disclosed Sep 21, 2026FILED +108 DAYS

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Bolt Biotherapeutics, Inc. (BOLT)." Disclosed 2026-09-21. https://desqlong.com/cards/cluster-BOLT-2026-06-05-d6b2eb5a5c3a (retrieved 2026-09-26).